24th -
25th
June 2025
June 2025 | 
Songdo Convensia, Incheon, South Korea

13 Years of Excellence: South Korea’s Biggest Biologics Manufacturing Conference

24th -
25th
June 2025 | 
Songdo Convensia, Incheon, South Korea
📆 Add to Google Calendar
Attendees
0 +
Organizations
0 +
Expert Speakers
0 +
Hours of In-person Networking
0 +
Co-located Events - CGTWEA & ADC 2025
0 +

In the fast-paced and ever-evolving world of biopharma, South Korea continues to assert itself as a global leader, driving innovation through sustained R&D investment and groundbreaking initiatives from both the public and private sectors. South Korea’s exceptional performance in public health during the Covid-19 pandemic has solidified its reputation as a biotech powerhouse on the international stage.

As we look to the future, 14th Biologics Manufacturing Korea 2025 aims to serve as the premier platform for collaboration, knowledge exchange, and strategic partnerships. This year's conference will delve into critical topics, including advanced strategies in upstream processing, the future of biomanufacturing through automation and AI technologies, insights on regulatory pathways for biosimilars and innovative approaches to downstream processing and supply chain optimization.

Biologics Manufacturing Korea 2025 will be co-located with the Cell and Gene Therapy East Asia 2025 and ADC and Bioconjugate East Asia 2025 events, enhancing the opportunity for interdisciplinary discussions and collaboration.

Join us at Biologics Manufacturing Korea 2025 to connect with key players shaping Korea’s biopharma landscape, including leaders from Samsung Biologics, Celltrion, SK bioscience, Hanmi Pharmaceuticals, Lotte Biologics, and more. If Korea is your gateway to growth in the biomanufacturing space, Biologics Manufacturing Korea 2025 is the destination where innovation meets opportunity.

FEATURED CONTENT

ebook-cover
The New Frontier in Vaccine Innovation and Excellence
Ebook 2 website cover 1440 x 478 2
Exploring South Korea's mRNA Biopharma Landscape: Key Players & Innovations
Advancements in Biologics Manufacturing in Korea
Advancements in Biologics Manufacturing in Korea
BMK23_Ebook-cover-1500-x-1500-1024x1024
5 Reasons Why You Should Expand To Korea
BMK23_Infographics-Cover-1024x1024
Korea Biopharma Distribution
cover
CMO Facilities Highlights
The-Handbook-of-Korean-Laws-and-Regulations-Impacting-Temperature-Controlled-Logistics-5-1-150-X-150-5
Songdo Bio-Cluster: Overview
Untitled design (4)
BMK24 Preliminary Attendee List
Untitled design (4)
Leading Biopharma in Korea in Phase 3 Clinical Pipeline
14th Biologics Manufacturing Korea 2025

A dialogue among industry leaders examining the current landscape, challenges, and opportunities in South Korea’s biologics manufacturing sector.

Insights into how automation and Industry 4.0 technologies are transforming biomanufacturing processes for enhanced efficiency and quality.

Best practices and innovative strategies for improving cell culture processes to maximize yield and support the development of advanced therapies.

An overview of the regulatory landscape and key considerations for successfully bringing biosimilars to market.

Strategies and technologies to optimize purification processes and improve overall yield in biologics production.

Exploring modern facility design principles and capacity planning strategies to meet the demands of a rapidly evolving biopharma landscape.

Discussing the importance of analytics in maintaining product quality and compliance with regulatory standards throughout the manufacturing process.

Innovative solutions and best practices for optimizing the supply chain, focusing on fill-finish processes and packaging to ensure product integrity.

THANK YOU TO OUR SUPPORTING PARTNERS









PAST SPONSORS

14th Biologics Manufacturing Korea 2025

Past Speakers

Bonghee Lee

Chief Executive Officer,

nSAGE,
South Korea

Brian Curran

SVP Manufacturing Excellence Success

MasterControl
USA

Darshana Jain

Technical Developer Manager - Greater Asia & China

Roquette
India

Donggoo Bae

Chief Technology Officer

Genuv
South Korea

Hemasunder Reddy

Director-Asia Pacific

Pfanstiehl
Singapore

HoJin Lee

Head of Biologics Manufacturing Plant

Daewoong Bio
South Korea
Hoon Sang Lee

Hoon Sang Lee

Chief Scientific Officer

Right Foundation
South Korea

Imroz Ghangas

Senior Director of Business Development

Asimov
United States

John Locklear

Senior Manager, Technical Support and Assay Development

Cygnus Technologies, LLC
United States

Jonggu Kim

Quality Director

Lotte Biologics
South Korea

Justin Yoo

Ceo/ Founder

YOUTH BIO GLOBAL
South Korea

Kevin Montagne

Business Development Associate in the Biopharmaceutical, Gene Therapy Unit

Chitose Laboratory Corp.
Japan

KwangJun Yoon

Managing Director

CHA Biotech
South Korea

Manh-Cuong VO

General Manager, R&D Center

Vaxcell-Bio
South Korea
Min Jeong Kye photo

Min Jeong Kye

VP, Chief Technology Officer

Curigin
South Korea

Neil Gharat

Chief Development Officer

Yuyu Pharma
South Korea

Shin-Il Kim

Chief Scientific Officer

THERABEST,
South Korea

Weon-Kyoo You

Executive Vice President

ABL Bio
South Korea

WonHyun Hwang (James)

Head of biopharma application, Asis Middle East and Africa

Avantor Performance Materials Korea Ltd.

YoungMin Oh

Managing Director, Head of SMART Team

GI Innovation
Korea

DELEGATE REGISTRATION

APAC Biopharma / Academic

Coming soon.

Service or Solution Provider / Big Pharma

Coming soon.

DELEGATE REGISTRATION

Catch the limited super access in time to save BIG!

APAC Biopharma / Academic

Coming soon.

Service or Solution Provider / Big Pharma

Coming soon.

Prestige Biologics Site Tour - in conjunction with 14th Biologics Manufacturing Korea 2025

Prestige Biologics is established in 2015 and completed its first plant in Chungbuk Osong Life Science Complex in 2018. The four plants have a total manufacturing capacity of 154,000 liters. Plants 1, 2, and 3 are equipped with single-use technology, while Plant 4 has implemented the 'Hybrid ALITA Smart BioFactory™'. 'Hybrid ALITA Smart BioFactory™' combines the advantages of single-use systems and stainless steel, which is achieving outstanding performance.  

The facility received GMP certification from the Ministry of Food and Drug Safety (MFDS) in Korea and the European Union (EU) in 2019 and 2021, respectively. US FDA inspections for both campuses are expected in 2025. 

Prestige Biologics offers a 'One-Stop Solution' that meets customer needs throughout the entire process of biopharmaceutical production, including manufacturing process development, production of clinical samples, step-by-step regulatory support, and commercial production. 

Attending? Contact [email protected] to express your interest.

FEATURED CONTENT

ebook-cover
The New Frontier in Vaccine Innovation and Excellence
Ebook 2 website cover 1440 x 478 2
Exploring South Korea's mRNA Biopharma Landscape: Key Players & Innovations
Advancements in Biologics Manufacturing in Korea
Advancements in Biologics Manufacturing in Korea
BMK23_Ebook-cover-1500-x-1500-1024x1024
5 Reasons Why You Should Expand To Korea
BMK23_Infographics-Cover-1024x1024
Korea Biopharma Distribution
cover
CMO Facilities Highlights
The-Handbook-of-Korean-Laws-and-Regulations-Impacting-Temperature-Controlled-Logistics-5-1-150-X-150-5
Songdo Bio-Cluster: Overview
Untitled design (4)
BMK24 Preliminary Attendee List
Untitled design (4)
Leading Biopharma in Korea in Phase 3 Clinical Pipeline

#BUZZ ABOUT THE EVENT

SIMILAR EVENTS

Register Now. SAVE BIG!

Download Post Event Report Form

Download Participating Companies

IMAPAC requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and to learn more about our privacy practices and our commitment to protecting your privacy, please review our Privacy Policy.

Download Attendee List

Download Prospectus Document Form

Brochure Form

Sponsorship Form

IMAPAC requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and to learn more about our privacy practices and our commitment to protecting your privacy, please review our Privacy Policy.

Download Agenda Form

Apply For Speaking Opportunity

Featured Content Form

Download List of Biopharma Companies in Asia Brochure

Download Ebook

Download Ebook

VWSEA2024 Brochure

Download List of Biopharma, CMO, CRO, CDMO and Big Pharma in China and Taiwan Brochure

Download Strategic Consulting Brochure

Download Case Study Consulting Digital Disruption

Download Case Study Consulting Revolutionizing Biopharmaceuticals

Download IMAPAC Custom Events Prospectus

Download Case Study : Fill-Finish Solution provider increasing its market share

Download Case Study : European CMO expanding into APAC

Download Case Study : China CDMO's New Gene Protein Facility Opening

Download Biologics Newsletter

Download Cell and Gene Therapy Newsletter

Download Vaccines Newsletter

Download 1:1 Networking Meetings Case Study- High-end assembly solutions provider

Download 1:1 Networking Meetings Case Study- IT/Software Solution provider

Download 1:1 Networking Meetings Case Study

Download Ebook

Download Ebook

Download Events Calendar

Customised Webinar/Webcast

Download Customised Events Brochure

Contact us for Third Party Email Services

Download Newsletter Press Kit

Download Network Meetings Prospectus

Download Media Kit

Download Form

Cell and Gene Therapy World Summit Brochure

    Contact Form


    IMAPAC requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and to learn more about our privacy practices and our commitment to protecting your privacy, please review our Privacy Policy.

    Download Brochure Sample

      Contact Form


      IMAPAC requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and to learn more about our privacy practices and our commitment to protecting your privacy, please review our Privacy Policy.